Zobrazeno 1 - 10 of 61 pro vyhledávání: '"Cara L McDermott"'
1
Akademický článek
Utilization patterns and characteristics of users of biologic anti‐inflammatory agents in a large, US commercially insured population
Autor: Aaron B. Mendelsohn, Young Hee Nam, James Marshall, Cara L. McDermott, Bharati Kochar, Michael D. Kappelman, Jeffrey S. Brown, Catherine M. Lockhart
Publikováno v: Pharmacology Research & Perspectives, Vol 9, Iss 1, Pp n/a-n/a (2021)
Abstract We report utilization patterns and characteristics of patients treated with biologic anti‐inflammatory agents in a large commercially insured patient population in the United States. We identified adult (age ≥18 years) patients receiving
Externí odkaz: https://doaj.org/article/1cf89d930c90443cb5ca9898ef8be72c
Zobrazit plný text záznamu
3
Akademický článek
Outpatient directly observed therapy for hepatitis C among people who use drugs: a systematic review and meta-analysis
Autor: Cara L. McDermott, Catherine M. Lockhart, Beth Devine
Publikováno v: Journal of Virus Eradication, Vol 4, Iss 2, Pp 118-122 (2018)
Objective:We conducted a meta-analysis of randomised studies that assessed the effectiveness of directly observed hepatitis C medication therapy delivered in outpatient clinics compared to treatment as usual.Methods:We completed a systematic literatu
Externí odkaz: https://doaj.org/article/25841da870ef472eb7cc3884016e4cd5
Zobrazit plný text záznamu
4
Advance Care Planning Documentation and Intensity of Care at the End of Life for Adults With Congestive Heart Failure, Chronic Kidney Disease, and Both Illnesses
Autor: Lyndia C. Brumback, Nisha Bansal, Daniel D. Matlock, Cara L. McDermott, Ann M. O’Hare, J R. Curtis, Gwen M. Bernacki, James N. Kirkpatrick, Ruth A. Engelberg
Publikováno v: J Pain Symptom Manage
Context Heart failure (HF) and chronic kidney disease (CKD) are associated with high morbidity and mortality, especially in combination, yet little is known about the impact of these conditions together on end-of-life care. Objectives Compare end-of-
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5397863110c5ed110cded93a11c6757c
https://doi.org/10.1016/j.jpainsymman.2021.07.030
Zobrazit plný text záznamu
5
Effect of the COVID-19 Pandemic on Place of Death Among Medicaid and Commercially Insured Patients With Cancer in Washington State
Autor: Laura E. Panattoni, Cara L. McDermott, Li Li, Qin Sun, Catherine R. Fedorenko, Hayley A. Sanchez, Karma L. Kreizenbeck, Veena Shankaran, Scott D. Ramsey
Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
PURPOSE The COVID-19 pandemic–related disruptions in health care delivery might have affected end-of-life care in patients with cancer. We examined changes in place of death and hospice support for Medicaid and commercially insured patients during
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45a968624a291292b0d357517eb5dac9
https://pubmed.ncbi.nlm.nih.gov/36417688
Zobrazit plný text záznamu
6
Methodological Challenges for Epidemiologic Studies of Deprescribing at the End of Life
Autor: Attah K Mbrah, Cara L. McDermott, Jennifer L. Lund, Seun Osundolire, Jennifer Tjia, Deborah S Mack, Yiyang Yuan, Qiaoxi Chen
Publikováno v: Current epidemiology reports
Purpose of Review To describe approaches to measuring deprescribing and associated outcomes in studies of patients approaching end of life (EOL). Recent Findings We reviewed studies published through 2020 that evaluated deprescribing in patients with
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::390ca11566b7a2c9ec49e59359dd8d7b
https://doi.org/10.1007/s40471-021-00264-7
Zobrazit plný text záznamu
7
Polypharmacy, chemotherapy receipt, and medication-related out-of-pocket costs at end of life among commercially insured adults with advanced cancer
Autor: J. Randall Curtis, Karma L. Kreizenbeck, Catherine R. Fedorenko, Cara L. McDermott, Scott D. Ramsey, Qin Sun
Publikováno v: J Oncol Pharm Pract
Background Polypharmacy raises the risk of drug-drug interactions and adverse events among patients with cancer. Most polypharmacy research has focused on adults age 65 or older enrolled in Medicare insurance. To better inform pharmacy practice and c
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7e7cca8623eca56d1979f79bbf64ec2
https://doi.org/10.1177/10781552211006180
Zobrazit plný text záznamu
8
Patient Characteristics and Utilization Patterns of Short-Acting Recombinant Granulocyte Colony-Stimulating Factor (G-CSF) Biosimilars Compared to Their Reference Product
Autor: Jeffrey S. Brown, Aaron B. Mendelsohn, Catherine M Lockhart, James Marshall, Cara L. McDermott, Pamala A. Pawloski
Publikováno v: Drugs-Real World Outcomes
Background Data on short-acting recombinant granulocyte colony-stimulating factor (G-CSF) biosimilar utilization from claims data in the USA are limited. Objective To evaluate patient baseline characteristics and utilization patterns for short-acting
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec29171af69bd78469a7cbe767abd924
http://europepmc.org/articles/PMC7847294
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje